You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
11 April 2022
Dipeptidyl peptidase 3 biomarker to drive precision medicine in COVID-19
15 April 2021
DPP3 biomarker to advance prediction of organ function progression in septic patients
25 March 2021
4TEEN4 Pharmaceuticals GmbH: DPP3 predicts organ failure and in-hospital mortality in post-operative patients
16 September 2020
4TEEN4’s first-in-class therapeutic antibody Procizumab restores heart function in life-threatening cardiac depression induced by sepsis
5 December 2019
Biotech Startup 4TEEN4 Pharmaceuticals Closes EUR 7 Million Series A Financing
31 August 2019
4TEEN4 Pharmaceuticals reports first results on Procizumab, a novel therapeutic anti-DPP3 antibody for treatment of acute myocardial depression